The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Drug–target interaction prediction by random walk on the heterogeneous network
Abstract
Predicting potential drug–target interactions from heterogeneous biological data is critical not only for better understanding of the various interactions and biological processes, but also for the development of novel drugs and the improvement of human medicines. In this paper, the method of Network-based Random Walk with Restart on the Heterogeneous network (NRWRH) is developed to predict potential drug–target interactions on a large scale under the hypothesis that similar drugs often target similar target proteins and the framework of Random Walk. Compared with traditional supervised or semi-supervised methods, NRWRH makes full use of the tool of the network for data integration to predict drug–target associations. It integrates three different networks (protein–protein similarity network, drug–drug similarity network, and known drug–target interaction networks) into a heterogeneous network by known drug–target interactions and implements the random walk on this heterogeneous network. When applied to four classes of important drug–target interactions including enzymes, ion channels, GPCRs and nuclear receptors, NRWRH significantly improves previous methods in terms of cross-validation and potential drug–target interaction prediction. Excellent performance enables us to suggest a number of new potential drug–target interactions for drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of common molecular subsequences
Smith, T. F., & Waterman, M. S. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90087-5 · Cited by 9,940
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
From genomics to chemical genomics: new developments in KEGG
Kanehisa, M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj102 · Cited by 3,120
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
A Fast Flexible Docking Method using an Incremental Construction Algorithm
Rarey, M., Kramer, B., Lengauer, T., & Klebe, G. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0477 · Cited by 2,827
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Walking the Interactome for Prioritization of Candidate Disease Genes
Köhler, S., Bauer, S., Horn, D., & Robinson, P. N. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.02.013 · Cited by 1,258
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248
Prediction of drug–target interaction networks from the integration of chemical and genomic spaces
Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W., & Kanehisa, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn162 · Cited by 1,147
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
BRENDA, the enzyme database: updates and major new developments
Schomburg, I. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh081 · Cited by 953
Gaussian interaction profile kernels for predicting drug–target interaction
van Laarhoven, T., Nabuurs, S. B., & Marchiori, E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr500 · Cited by 934
SuperTarget and Matador: resources for exploring drug-target relationships
Gunther, S., Kuhn, M., Dunkel, M., Campillos, M., Senger, C., Petsalaki, E., Ahmed, J., Urdiales, E. G., Gewiess, A., Jensen, L. J., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm862 · Cited by 647
Supervised prediction of drug–target interactions using bipartite local models
Bleakley, K., & Yamanishi, Y. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp433 · Cited by 628
Hattori, M., Okuno, Y., Goto, S., & Kanehisa, M. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036030u · Cited by 484
Yamanishi, Y., Kotera, M., Kanehisa, M., & Goto, S. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq176 · Cited by 470
Genome-wide inferring gene–phenotype relationship by walking on the heterogeneous network
Li, Y., & Patra, J. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq108 · Cited by 418
Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces
Xia, Z., Wu, L.-Y., Zhou, X., & Wong, S. T. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-s2-s6 · Cited by 389
Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays
Kuruvilla, F. G., Shamji, A. F., Sternson, S. M., Hergenrother, P. J., & Schreiber, S. L. (2002) · Nature · doi:10.1038/416653a · Cited by 367
On the Properties of Bit String-Based Measures of Chemical Similarity
Flower, D. R. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci970437z · Cited by 345
Frantz, S. (2005) · Nature · doi:10.1038/437942a · Cited by 322
Drugs and their molecular targets: an updated overview
Landry, Y., & Gies, J. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00548.x · Cited by 208
Haggarty, S. J., Koeller, K. M., Wong, J. C., Butcher, R. A., & Schreiber, S. L. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00095-4 · Cited by 201
Finding multiple target optimal intervention in disease‐related molecular network
Yang, K., Bai, H., Ouyang, Q., Lai, L., & Tang, C. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.60 · Cited by 186
Godden, J. W., Xue, L., & Bajorath, J. (1999) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci990316u · Cited by 149
Prediction of potential drug targets based on simple sequence properties
Li, Q., & Lai, L. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-353 · Cited by 116
A Novel Candidate Disease Genes Prioritization Method Based on Module Partition and Rank Fusion
Chen, X., Yan, G., & Liao, X. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2009.0143 · Cited by 25
Self-citation
Cited by
Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment
Zhang, R., Zhu, X., Bai, H., & Ning, K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00123 · Cited by 1,257
Zhao, L., Zhang, H., Li, N., Chen, J., Xu, H., Wang, Y., & Liang, Q. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116306 · Cited by 963
Luo, Y., Zhao, X., Zhou, J., Yang, J., Zhang, Y., Kuang, W., Peng, J., Chen, L., & Zeng, J. (2017) · Nature Communications · doi:10.1038/s41467-017-00680-8 · Cited by 916
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Drug–target interaction prediction: databases, web servers and computational models
Chen, X., Yan, C. C., Zhang, X., Zhang, X., Dai, F., Yin, J., & Zhang, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv066 · Cited by 658
Self-citation
Metadata
- Authors
- Chen, X., Liu, M.-X., & Yan, G.-Y.
- Venue
- Molecular BioSystems
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-15
- Volume
- 8
- Issue
- 7
- Pages
- 1970-1978
- ISSN
- 1742-2051 (ISSN-L)
- 1742-206X
- OpenAlex
- W1971106435
- Cited by
- 533
- References
- 28
- FWCI
- 19.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.